2023 South Dakota Codified Laws
Title 34 - Public Health and Safety
Chapter 20B - Drugs And Substances Control
Section 34-20B-12 - Specific substances included in Schedule I.
34-20B-12. Specific substances included in Schedule I.
Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule I, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
(1)Acetylmethadol;
(2)Allylprodine;
(3)Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM;
(4)Alphameprodine;
(5)Alphamethadol;
(6)Benzethidine;
(7)Betacetylmethadol;
(8)Betameprodine;
(9)Betamethadol;
(10)Betaprodine;
(11)Clonitazene;
(12)Dextromoramide;
(13)Diampromide;
(14)Diethyliambutene;
(15)Dimenoxadol;
(16)Dimepheptanol;
(17)Dimethyliambutene;
(18)Dioxaphetyl butyrate;
(19)Dipipanone;
(20)Ethylmethylthiambutene;
(21)Etonitazene;
(22)Etoxeridine;
(23)Furethidine;
(24)Hydroxypethidine;
(25)Ketobemidone;
(26)Levomoramide;
(27)Levophenacylmorphan;
(28)Mecloqualone;
(29)Morpheridine;
(30)Noracymethadol;
(31)Norlevorphanol;
(32)Normethadone;
(33)Norpipanone;
(34)Phenadoxone;
(35)Phenampromide;
(36)Phenomorphan;
(37)Phenoperidine;
(38)Piritramide;
(39)Proheptazine;
(40)Properidine;
(41)Racemoramide;
(42)Trimeperidine;
(43)Methaqualone;
(44)N-benzylpiperazine;
(45)4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide, W-18;
(46)N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, also known as isotonitazene;
(47)2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene);
(48)2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene, etazene);
(49)N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (flunitazene);
(50)N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (metodesnitazene);
(51)N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (metonitazene);
(52)2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (N-pyrrolidino etonitazene, etonitazepyne); and
(53)N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene).
Source: SL 1970, ch 229, §8 (a) (1); SDCL Supp, §39-17-55; SL 1977, ch 315, §1; SL 1985, ch 278, §50; SL 1994, ch 278, §1; SL 2003, ch 183, §1; SL 2018, ch 203, §1, eff. Feb. 8, 2018; SL 2021, ch 144, §1, eff. Feb. 17, 2021; SL 2022, ch 109, §1, eff. Feb. 9, 2022.